Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.5ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
A.5ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
A.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
A.5SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
A.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.422ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.422ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.422SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.422SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.422EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.422EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.422NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.422NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.6ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.6ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.6SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.6SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.56ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.56ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.56SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.56SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.56EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.56NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GT.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.87ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBB.1.5.87ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.1.5.87SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.5.87SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBB.1.5.87EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.87NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.87NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAPORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XAPORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XAPSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XAPSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XAPEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used